Meeting to be held in New York on October 7 hosted by Cantor Fitzgerald.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ESPR:
- Esperion price target raised to $9 from $7 at Cantor Fitzgerald
- Esperion’s US Market Stagnation Overshadows Japanese Approval, Justifying Sell Rating
- Esperion’s Strategic Milestone: Nexletol Approval in Japan Boosts Financial Outlook with $120 Million Potential
- Esperion’s Strategic Advancements: Regulatory Approval and Market Expansion Boost
- Esperion announces Otsuka received approval to market NEXLETOL in Japan